01/02/2025
11:15 PM | Aptevo Therapeutics (Filer)
| Form EFFECT | |
12/20/2024
3:30 PM | Aptevo Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
12/12/2024
4:15 PM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2024
8:05 AM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/04/2024
7:45 AM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/03/2024
4:05 PM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/26/2024
7:45 AM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/22/2024
7:45 AM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2024
7:45 AM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
1:57 PM | Aptevo Therapeutics (Subject)
Hudson Bay Capital Management LP (Filed by)
| Form SC 13G | |
11/07/2024
7:30 AM | Aptevo Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
|
11/07/2024
7:15 AM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/25/2024
3:30 PM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/23/2024
3:48 PM | Aptevo Therapeutics (Filer)
| Form PRE 14A | |
09/18/2024
3:07 PM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2024
4:28 PM | Aptevo Therapeutics (Filer)
| Form 424B4 | |
09/16/2024
11:15 PM | Aptevo Therapeutics (Filer)
| Form EFFECT | |
09/16/2024
7:09 AM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/30/2024
4:26 PM | Aptevo Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
08/09/2024
3:30 PM | Aptevo Therapeutics (Issuer)
Taylor Daphne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
3:33 PM | Aptevo Therapeutics (Issuer)
Lamothe Jeffrey G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
3:35 PM | Aptevo Therapeutics (Issuer)
Kwon SoYoung (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
7:30 AM | Aptevo Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024
7:15 AM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2024
3:30 PM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2024
3:32 PM | Aptevo Therapeutics (Issuer)
Niederhuber John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
3:34 PM | Aptevo Therapeutics (Issuer)
White Marvin L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
3:35 PM | Aptevo Therapeutics (Issuer)
Lamothe Jeffrey G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
3:35 PM | Aptevo Therapeutics (Issuer)
Kwon SoYoung (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
3:36 PM | Aptevo Therapeutics (Issuer)
Grant Grady III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
3:37 PM | Aptevo Therapeutics (Issuer)
Taylor Daphne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
3:38 PM | Aptevo Therapeutics (Issuer)
Harsanyi Zsolt (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
3:30 PM | Abdun-Nabi Daniel (Reporting)
Aptevo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
3:31 PM | Aptevo Therapeutics (Issuer)
Kunz Barbara Lopez (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/15/2024
7:19 AM | Aptevo Therapeutics (Filer)
| Form DEF 14A | |
07/12/2024
3:30 PM | Aptevo Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
07/03/2024
3:30 PM | Aptevo Therapeutics (Filer)
| Form PRE 14A | |
06/30/2024
11:15 PM | Aptevo Therapeutics (Filer)
| Form EFFECT | |
06/26/2024
7:30 AM | Aptevo Therapeutics (Filer)
| Form S-1/A | |
06/14/2024
3:30 PM | Aptevo Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
06/10/2024
3:30 PM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad) Elon Musk believes his new AI product will be worth an incredible $9 trillion.
But the mainstream media is not buying it. Click here to watch this demo and decide for yourself. |
06/03/2024
3:31 PM | Aptevo Therapeutics (Issuer)
Kwon SoYoung (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
7:30 AM | Aptevo Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/08/2024
7:15 AM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2024
3:05 PM | Aptevo Therapeutics (Filer)
| Form DEF 14A | |
04/23/2024
3:10 PM | Aptevo Therapeutics (Filer)
| Form DEFA14A | |
04/23/2024
3:15 PM | Aptevo Therapeutics (Filer)
| Form ARS | |
04/12/2024
4:23 PM | Aptevo Therapeutics (Filer)
| Form 424B4 | |
04/10/2024
11:15 PM | Aptevo Therapeutics (Filer)
| Form EFFECT | |
04/09/2024
4:26 PM | Aptevo Therapeutics (Filer)
| Form S-1/A | |
03/29/2024
4:00 PM | Aptevo Therapeutics (Filer)
| Form S-1/A | |
03/20/2024
3:15 PM | Aptevo Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
03/07/2024
7:56 AM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
7:30 AM | Aptevo Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/05/2024
7:15 AM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
2:24 PM | Aptevo Therapeutics (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
| Form SC 13G | |
02/06/2024
3:37 PM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
